According to a recent resolution signed by the Costa Rican Ministry of Agriculture, the country has authorized agricultural groups to grow and process marijuana for the first time.
Agricultural and food company, Ingenio Taboga SA, has announced plans to cultivate cannabis on 150 acres of land and construct a processing plant.
According to a report by "Today's Cannabis", Taboga, located in Guanacaste, Bedaro de Canias, has listed alcohol-based disinfectants, specialty sugars, natural sweeteners, protein powders and CBD products on its website.
Minister of Agriculture, Víctor Carvajal, stated that "the development of responsible and efficient agricultural activities with huge potential for agricultural exports is extremely important for the Ministry of Agriculture and Livestock." He also added that seven cannabis projects are currently being considered for approval, with the expectation of receiving approval soon.
Under rules approved by agricultural and health officials in September, licenses for cannabis cultivation and production are intended to be affordable and widely available in Costa Rica. Individuals and legal entities can be authorized to grow and process cannabis and establish rules for harvesting, storage, transportation, product manufacturing, marketing, import, and export of health, food, and industrial products.
Costa Rica's regulations have set the limit for tetrahydrocannabinol (THC) in marijuana plants at 1.0%. Most countries adhere to the widely accepted 0.3% THC threshold as the line between hemp and marijuana.
Advocates in Costa Rica's industry have said that establishing a robust marijuana sector could stimulate the development of the agriculture value chain by bringing economic and social opportunities to rural areas in the country, while also aiding the development of the pharmaceutical industry.
2FIRSTS will continue to provide coverage on this topic, with further updates available on the "2FIRSTSAPP." Scan the QR code below to download the app.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
